LOGIN
Ajulemic acid effective in reduction of chronic neuropathic pain, with minimal side effects
September 2018
Ajulemic acid effective in reduction of chronic neuropathic pain, with minimal side effects
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Pain measurements and side effect profile of the novel cannabinoid ajulemic acid
Neuropharmacology. 2005 Jun;48(8):1164-71Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
21 patients experiencing chronic neuropathic pain were randomly assigned to receive orally administered ajulemic acid (AJA), a synthetic cannabinoid, or placebo for 7 days, with a 7-day baseline period prior to the treatment. They then underwent a 7-day washout period, followed by another 7-day baseline period, and were crossed-over to receive the other intervention for 7 days. Participants were a...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.